Stryker
Stryker's Mako SmartRobotics now covers knee, hip and (in full market release from 2026) shoulder arthroplasty, with the handheld Mako RPS entering limited release in February 2026; Stryker reported $11.2 billion in 2025 orthopedic sales.
- Country
- United States
- Ticker
- NYSE:SYK
Surgical robotics
Orthopedic implants
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biomedical engineering & implants | regenerative-personalized | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.